Sino Biopharmaceutical Limited
SBMFF
$0.70
Updated: 23/09/2026, 15:42:25
Market Cap
$12.38B
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Country
HK
Stock valuation chart
One-year closing share-price history for SBMFF
Company Profile
Sino Biopharmaceutical Limited is an investment holding company that operates as an integrated pharmaceutical enterprise. It researches, develops, manufactures, and markets a wide range of modernized Chinese medicines and chemical medicines. The company's therapeutic areas of focus include oncology, liver disease, respiratory, and surgery/pain relief, with its primary market being mainland China. [9, 12, 15, 19]
USD
OTC
CEO: S. Y. Tse
Employees: 21,435
Asset Summaries
Latest generated summaries for SBMFF
No summaries found.
Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for SBMFF.
- Share price
- $0.70
- Market cap
- $12.38B
- Exchange
- OTC
- Currency
- USD
- CEO
- S. Y. Tse
- Employees
- 21,435
- IPO date
- 22/02/2010
- Beta
- 0.605
- Last dividend
- $0.00
- Day range
- $0.65 – $0.70
- 52-week range
- $0.59 – $1.09
- 1-day performance
- 0.00%
- 1-year performance
- 17.20%
- Current drawdown (1Y)
- -36.24%
- CIK
- 0001604982
- CUSIP
- G8167W138
- ISIN
- KYG8167W1380
- Created
- 07/12/2025, 14:07:27
- Last update
- 23/09/2026, 15:42:25
Track Sino Biopharmaceutical Limited with an AI analyst
See which prediction-market events move SBMFF, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Latest Database News
News linked to SBMFF from your Railway `news_articles` table.
No news found for this symbol.